cas 4652-27-1|| where to buy 4-Methoxybut-3-en-2-one

Produktname:4-Methoxybut-3-en-2-one

IUPAC Name:(3E)-4-methoxybut-3-en-2-one

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM244519-100g	in stock	ǫȯƿ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 4652-27-1 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:4652-27-1; Molekulare Formel:C5H8O2; Schmelzpunkt:-; SMILES-Code:CC(/C=C/OC)=O; Dichte:

: Katalognummer:CM244519; Molekulargewicht:100.12; Siedepunkt:; Mdl-Nr.:MFCD00008778; Lagerung:Protect from light and store in a dry and close container at 2°C~8°C

: Aliphatic Chain Compounds; Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

: Vijoice; Recently, the FDA approved Vijoice (alpelisib) as a new dosage form of oral granules. Vijoice is the first FDA-approved treatment for patients with PROS. PROS are a group of genetic disorders in which mutations occur in the PIK3CA gene, causing overgrowth of certain body parts. Vijoice treats the condition by inhibiting the PI3K/Akt signalling pathway.